Have your own idea? Try our Stock Screener
Canadian (TSX) Clinical Research and Equipment Industry Analysis
UpdatedJan 22, 2025
DataAggregated Company Financials
Companies2
- 7D3.3%
- 3M2.7%
- 1Y66.0%
- YTDn/a
Sona Nanotech is up 1.9%, leading the way for the Clinical Research and Equipment industry, which has gained 1.8%. Meanwhile, Rapid Dose Therapeutics actually underperformed within the industry, shrinking 11% in the last week. This means that the industry has gained 73% over the past year.
Industry Valuation and Performance
Has the Canadian Clinical Research and Equipment Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Wed, 22 Jan 2025 | CA$31.4m | CA$5.9m | -CA$1,591,902.00 | n/a | -19.7x | 5.3x |
| Fri, 20 Dec 2024 | CA$27.5m | CA$5.4m | -CA$1,321,782.00 | n/a | -20.8x | 5.1x |
| Sun, 17 Nov 2024 | CA$25.3m | CA$5.1m | -CA$1,418,028.00 | n/a | -17.8x | 4.9x |
| Tue, 15 Oct 2024 | CA$28.3m | CA$5.1m | -CA$1,418,028.00 | n/a | -20x | 5.5x |
| Thu, 12 Sep 2024 | CA$59.2m | CA$5.1m | -CA$4,554,454.00 | n/a | -13x | 11.5x |
| Sat, 10 Aug 2024 | CA$61.8m | CA$5.1m | -CA$4,366,737.00 | n/a | -14.1x | 12x |
| Mon, 08 Jul 2024 | CA$58.7m | CA$4.9m | -CA$4,098,591.00 | n/a | -14.3x | 11.9x |
| Wed, 05 Jun 2024 | CA$65.7m | CA$4.9m | -CA$3,824,483.00 | n/a | -17.2x | 13.3x |
| Fri, 03 May 2024 | CA$55.3m | CA$4.9m | -CA$3,805,287.00 | n/a | -14.5x | 11.4x |
| Sun, 31 Mar 2024 | CA$68.0m | CA$4.9m | -CA$3,306,237.00 | n/a | -20.6x | 13.8x |
| Tue, 27 Feb 2024 | CA$54.0m | CA$4.9m | -CA$1,290,813.00 | n/a | -41.8x | 11x |
| Thu, 25 Jan 2024 | CA$210.1m | CA$23.4m | -CA$24,636,048.00 | n/a | -8.5x | 9x |
| Sat, 23 Dec 2023 | CA$203.0m | CA$23.4m | -CA$24,636,048.00 | n/a | -8.2x | 8.7x |
| Mon, 20 Nov 2023 | CA$197.5m | CA$23.7m | -CA$24,695,492.00 | n/a | -8x | 8.3x |
| Wed, 18 Oct 2023 | CA$198.9m | CA$23.7m | -CA$24,695,492.00 | n/a | -8.1x | 8.4x |
| Fri, 15 Sep 2023 | CA$196.4m | CA$23.7m | -CA$24,644,997.00 | n/a | -8x | 8.3x |
| Sun, 13 Aug 2023 | CA$197.4m | CA$23.5m | -CA$24,780,404.00 | n/a | -8x | 8.4x |
| Tue, 11 Jul 2023 | CA$197.4m | CA$23.5m | -CA$24,780,404.00 | n/a | -8x | 8.4x |
| Thu, 08 Jun 2023 | CA$174.0m | CA$22.5m | -CA$25,042,100.00 | n/a | -6.9x | 7.7x |
| Sat, 06 May 2023 | CA$173.7m | CA$22.5m | -CA$24,991,382.00 | n/a | -6.9x | 7.7x |
| Mon, 03 Apr 2023 | CA$188.7m | CA$23.0m | -CA$29,977,765.00 | 39x | -6.3x | 8.2x |
| Wed, 01 Mar 2023 | CA$192.4m | CA$23.0m | -CA$29,977,765.00 | 39x | -6.4x | 8.4x |
| Fri, 27 Jan 2023 | CA$192.4m | CA$22.4m | -CA$30,499,829.00 | 39x | -6.3x | 8.6x |
| Sun, 25 Dec 2022 | CA$190.2m | CA$22.4m | -CA$30,499,829.00 | 35.1x | -6.2x | 8.5x |
| Tue, 22 Nov 2022 | CA$207.0m | CA$21.8m | -CA$30,309,915.00 | 39.1x | -6.8x | 9.5x |
| Thu, 20 Oct 2022 | CA$210.9m | CA$21.7m | -CA$30,373,079.00 | 72.1x | -6.9x | 9.7x |
| Sat, 17 Sep 2022 | CA$201.7m | CA$21.7m | -CA$30,373,079.00 | 76.6x | -6.6x | 9.3x |
| Mon, 15 Aug 2022 | CA$209.9m | CA$21.9m | -CA$23,995,882.00 | 22.4x | -8.7x | 9.6x |
| Wed, 13 Jul 2022 | CA$163.7m | CA$21.5m | -CA$26,689,749.00 | 20.5x | -6.1x | 7.6x |
| Fri, 10 Jun 2022 | CA$183.1m | CA$21.5m | -CA$26,689,749.00 | 19.9x | -6.9x | 8.5x |
| Sun, 08 May 2022 | CA$213.7m | CA$21.5m | -CA$26,635,227.00 | 18.6x | -8x | 9.9x |
| Tue, 05 Apr 2022 | CA$198.7m | CA$21.6m | -CA$23,635,914.00 | 25.2x | -8.4x | 9.2x |
| Thu, 03 Mar 2022 | CA$181.6m | CA$21.3m | -CA$21,103,914.00 | 26.6x | -8.6x | 8.5x |
| Sat, 29 Jan 2022 | CA$224.5m | CA$20.9m | -CA$20,076,847.00 | 26.6x | -11.2x | 10.7x |
Price to Earnings Ratio
-11.2x
Current Industry PE
- There are only 2 companies in the Canadian Life Sciences Tools and Services industry, so there is insufficient data to make an industry-wide assessment of both the PE and PS ratio.
Past Earnings Growth
- The earnings for companies in the Life Sciences Tools and Services industry have improved over the last three years.
- Meanwhile revenues for these companies have declined 34% per year.
- This means that less sales are being generated overall, but since the cost of doing business is lower, losses have been shrinking.
Industry Comparison
How does Canadian Clinical Research and Equipment compare with similar industries?
| CA Market | 2.73% | |
| Healthcare | 2.56% | |
| Life Sciences | 3.27% | |
| Clinical Research and Equipment | 3.27% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| IOT Innovotech | CA$0.20 | 11.1% +CA$994.3k | 100.0% | PS6.7x |